Altimmune, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Gaithersburg, MD
ALT chart
What traders are saying about $ALT
Latest postsAltimmune, Inc. news
- Altimmune adds two directors as three board members plan exit
Investing.com ·
- Form 8K Altimmune Inc For: 27 October By Investing.com
Investing.com Nigeria ·
- Altimmune adds Peter Greenleaf and Alex Howarth to board; three directors to retire
TradingView ·
- Three directors will retire in 2027 as Altimmune (ALT) names two incoming board members.
Stock Titan ·
- Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
Yahoo Finance ·
- Altimmune (ALT) Down -2.53% — Is the Sell-Off Overdone? 2026-10-23 - Volatility Stop
https://www.dars.gov.et/ ·
- Altimmune (ALT) Down -2.53% — Is the Sell-Off Overdone? 2026-10-23 - IV Rank
https://www.dars.gov.et/ ·
- Altimmune, Inc. Estimates – NASDAQ:ALT
TradingView ·
- Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026
Yahoo Finance ·
- Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?
Yahoo Finance ·
- Altimmune Details Pemvidutide’s Path Toward a Liver-Disease Franchise
marketbeat.com ·
- Altimmune to Participate in Stifel Cardiometabolic Forum
Yahoo Finance ·
Altimmune, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $41,000 | $20,000 | $426,000 | -$68,000 |
| Net income | -$88.1M | -$95.1M | -$88.4M | -$84.7M |
| Diluted EPS | $-1.00 | $-1.34 | $-1.66 | $-1.81 |
| Total assets (year end) | $279.9M | $139.3M | $210.6M | $206.9M |
| Cash and equivalents (year end) | $43.8M | $36.9M | $135.1M | $111.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Altimmune, Inc.
- Ticker
- ALT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1326190
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Frequently asked questions
What exchange is Altimmune, Inc. listed on?
Altimmune, Inc. trades on the Nasdaq under the ticker symbol ALT.
What industry is Altimmune, Inc. in?
Altimmune, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Altimmune, Inc. headquartered?
Altimmune, Inc.'s business address on file with the SEC is in Gaithersburg, MD.
When does Altimmune, Inc.'s fiscal year end?
Altimmune, Inc.'s fiscal year ends on December 31.
How much revenue did Altimmune, Inc. report?
Altimmune, Inc. reported $41,000 in revenue for calendar year 2025, according to its SEC filings.